Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
Status:
NOT_YET_RECRUITING
Trial end date:
2032-08-01
Target enrollment:
Participant gender:
Summary
The GISCO study plans to determine whether 8-week therapy is just as effective as 26-week cortisone therapy for treating giant cell arteritis
* with tocilizumab,
* while using less cortisone.